Increase in Capital Surplus Associated with a Share Exchange
First written in FY2019-Q2. 3 of 6 entries say "Restated". Latest entry: FY2024-Q3.
0 other companies' latest entry also says "Other".
- FY2024-Q3Increase in capital reserve through the share exchange involving マコト医科精機Annual report
「As a result of the share exchange conducted effective 30 April 2024, under which the Company became the wholly owning parent company and マコト医科精機㈱ became the wholly owned subsidiary, the number of issued shares increased by 222,390 and capital reserves increased by ¥172.797 million.」
The share exchange to make マコト医科精機 a wholly owned subsidiary resulted in an increase of 222,390 issued shares and ¥172.797 million in capital reserves. - FY2020RestatedAnnual report
「During the fiscal year, pursuant to Article 452 of the Companies Act and a resolution of the annual general meeting of shareholders held on 27 September 2019, other capital surplus of ¥390.687 million was reduced and transferred to retained earnings brought forward to offset the deficit. In addition, capital surplus decreased by ¥305.043 million in connection with the payment of a dividend funded by capital surplus, effective 30 September 2019.」
The annual report confirms the ¥390.687 million decrease in capital surplus to offset the deficit and the ¥305.043 million decrease resulting from the dividend funded by capital surplus. - FY2020-Q1Decrease in capital surplus due to deficit compensation and dividendsAnnual report
「During the first-quarter cumulative period, pursuant to Article 452 of the Companies Act and a resolution of the annual general meeting of shareholders held on 27 September 2019, other capital surplus of ¥390.687 million was reduced and transferred to retained earnings brought forward to offset the deficit. In addition, capital surplus decreased by ¥305.043 million in connection with the payment of a dividend funded by capital surplus, effective 30 September 2019.」
Capital surplus amounted to ¥2,611.508 million following the transfer of ¥390.687 million to offset the deficit and the ¥305.043 million decrease resulting from the dividend funded by capital surplus. - FY2019RestatedAnnual report
「New shares were issued in connection with a share exchange, effective 2 July 2018, under which the Company became the wholly owning parent company and ㈱ミタス and ディーセンス㈱ became wholly owned subsidiaries. This share exchange increased capital surplus by ¥2,184.335 million.」
The annual report also confirms the issuance of new shares and the ¥2,184.335 million increase in capital surplus resulting from the share exchange with ミタス and ディーセンス. - FY2019-Q3RestatedAnnual report
「This share exchange increased capital surplus by ¥2,184.335 million. In addition, capital surplus decreased by ¥272.336 million in connection with the payment of a dividend funded by capital surplus, effective 28 September 2018.」
Reiterates the increase in capital surplus from the share exchange with ミタス and ディーセンス and the decrease resulting from the dividend funded by capital surplus. - FY2019-Q2First statedAnnual report
「During the first-quarter cumulative period, new shares were issued in connection with a share exchange, effective 2 July 2018, under which the Company became the wholly owning parent company and ㈱ミタス and ディーセンス㈱ became wholly owned subsidiaries. This share exchange increased capital surplus by ¥2,184.335 million.」
States that new shares were issued in connection with the share exchange with ミタス and ディーセンス, increasing capital surplus by ¥2,184.335 million.